J Sludden
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 3
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 2
- Neutropenia and Cancer Infections 2
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- H. L. McLeod (4 shared papers)Alan V. Boddy (6 shared papers)Tao Li (1 shared paper)Collier (1 shared paper)Elaina Collie–Duguid (1 shared paper)Ruth Plummer (3 shared papers)Mark Verrill (2 shared papers)David Jamieson (2 shared papers)
- Journals
- British Journal of Cancer (5 papers)Journal of Pharmacy and Pharmacology (1 paper)Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
J Sludden
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Biomaterials 262
- Oncology 424
- Pharmacology 125
- Speech and Hearing 64
- Public Health, Environmental and Occupational Health 248
Countries citing papers authored by J Sludden
This map shows the geographic impact of J Sludden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Sludden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Sludden more than expected).
Fields of papers citing papers by J Sludden
This network shows the impact of papers produced by J Sludden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Sludden. The network helps show where J Sludden may publish in the future.
Co-authors
The 25 scholars most cited alongside J Sludden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 303 | |
| 2 | 1999 | 299 | |
| 3 | 2010 | 144 | |
| 4 | 1998 | 90 | |
| 5 | 1998 | 75 | |
| 6 | Ethnic differences in catechol O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals. | 1998 | 56 |
| 7 | 1998 | 41 | |
| 8 | 2014 | 30 | |
| 9 | 1999 | 23 | |
| 10 | 1999 | 20 | |
| 11 | 2000 | 19 | |
| 12 | Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors | 2003 | 6 |
| 13 | 2005 | 2 | |
| 14 | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer (vol 114, pg 723, 2016) | 2016 | 1 |
About J Sludden
J Sludden is a scholar working on Oncology, Molecular Biology, Pharmacology, Public Health, Environmental and Occupational Health and Genetics, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer Treatment and Pharmacology (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Neutropenia and Cancer Infections (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Biomaterials (262 citations), Oncology (424 citations), Pharmacology (125 citations), Speech and Hearing (64 citations) and Public Health, Environmental and Occupational Health (248 citations). J Sludden has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include H. L. McLeod, Alan V. Boddy, Tao Li, Collier, Elaina Collie–Duguid, Ruth Plummer, Mark Verrill, David Jamieson, Takako Nishiya and Melissa Griffin. Their work appears in journals such as British Journal of Cancer, Journal of Pharmacy and Pharmacology, Journal of Clinical Oncology, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.